Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 17116 | 617 | 25.2 | 46% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 275 | 3 | NSAIDS//CYCLOOXYGENASE//CYCLOOXYGENASE 2 | 43399 |
| 466 | 2 | NSAIDS//NON STEROIDAL ANTI INFLAMMATORY DRUGS//COX 2 INHIBITORS | 15930 |
| 17116 | 1 | ETODOLAC//EUROPEAN JOURNAL OF RHEUMATOLOGY AND INFLAMMATION//CAS 41340 25 4 | 617 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | ETODOLAC | authKW | 932912 | 9% | 36% | 53 |
| 2 | EUROPEAN JOURNAL OF RHEUMATOLOGY AND INFLAMMATION | journal | 297192 | 5% | 19% | 31 |
| 3 | CAS 41340 25 4 | authKW | 197955 | 1% | 100% | 4 |
| 4 | SDX 101 | authKW | 197955 | 1% | 100% | 4 |
| 5 | SDX 308 | authKW | 197955 | 1% | 100% | 4 |
| 6 | R ETODOLAC | authKW | 111348 | 0% | 75% | 3 |
| 7 | SDX 309 | authKW | 98978 | 0% | 100% | 2 |
| 8 | PIROXICAM BETA CYCLODEXTRIN | authKW | 79177 | 1% | 40% | 4 |
| 9 | RS ETODOLAC | authKW | 65984 | 0% | 67% | 2 |
| 10 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | journal | 59751 | 12% | 2% | 76 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Pharmacology & Pharmacy | 4838 | 52% | 0% | 318 |
| 2 | Rheumatology | 3882 | 15% | 0% | 90 |
| 3 | Medicine, Research & Experimental | 1475 | 19% | 0% | 117 |
| 4 | Medicine, General & Internal | 665 | 16% | 0% | 101 |
| 5 | Chemistry, Medicinal | 406 | 8% | 0% | 51 |
| 6 | Chemistry, Multidisciplinary | 36 | 8% | 0% | 50 |
| 7 | Toxicology | 31 | 3% | 0% | 18 |
| 8 | Chemistry, Analytical | 15 | 4% | 0% | 23 |
| 9 | Orthopedics | 11 | 2% | 0% | 11 |
| 10 | Sport Sciences | 2 | 1% | 0% | 6 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | CATTEDRA REUMATOL 1 | 49489 | 0% | 100% | 1 |
| 2 | CLIN ORTHOPED TRAUMATOL 2 | 49489 | 0% | 100% | 1 |
| 3 | CLIN SITE OPERAT ANALGESIA PSYCHIAT | 49489 | 0% | 100% | 1 |
| 4 | DPEIII | 49489 | 0% | 100% | 1 |
| 5 | IACS CIBEREHD | 49489 | 0% | 100% | 1 |
| 6 | JEFATURA O INVEST | 49489 | 0% | 100% | 1 |
| 7 | MED GEN REUMATOL | 49489 | 0% | 100% | 1 |
| 8 | MED METROPOLITANO | 49489 | 0% | 100% | 1 |
| 9 | ONKOL GEMEI AFTSPRAXIA | 49489 | 0% | 100% | 1 |
| 10 | SALMEDIX INC | 49489 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | EUROPEAN JOURNAL OF RHEUMATOLOGY AND INFLAMMATION | 297192 | 5% | 19% | 31 |
| 2 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 59751 | 12% | 2% | 76 |
| 3 | INVESTIGACION MEDICA INTERNACIONAL | 27234 | 1% | 8% | 7 |
| 4 | PHARMATHERAPEUTICA | 12708 | 1% | 3% | 9 |
| 5 | ACTA THERAPEUTICA | 9764 | 1% | 3% | 7 |
| 6 | CURRENT MEDICAL RESEARCH AND OPINION | 5852 | 4% | 1% | 23 |
| 7 | AGENTS AND ACTIONS | 3925 | 3% | 0% | 16 |
| 8 | CLINICAL THERAPEUTICS | 3581 | 3% | 0% | 19 |
| 9 | INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH | 2520 | 1% | 1% | 7 |
| 10 | CLINICAL TRIALS JOURNAL | 2223 | 1% | 1% | 4 |
Author Key Words |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ETODOLAC | 932912 | 9% | 36% | 53 | Search ETODOLAC | Search ETODOLAC |
| 2 | CAS 41340 25 4 | 197955 | 1% | 100% | 4 | Search CAS+41340+25+4 | Search CAS+41340+25+4 |
| 3 | SDX 101 | 197955 | 1% | 100% | 4 | Search SDX+101 | Search SDX+101 |
| 4 | SDX 308 | 197955 | 1% | 100% | 4 | Search SDX+308 | Search SDX+308 |
| 5 | R ETODOLAC | 111348 | 0% | 75% | 3 | Search R+ETODOLAC | Search R+ETODOLAC |
| 6 | SDX 309 | 98978 | 0% | 100% | 2 | Search SDX+309 | Search SDX+309 |
| 7 | PIROXICAM BETA CYCLODEXTRIN | 79177 | 1% | 40% | 4 | Search PIROXICAM+BETA+CYCLODEXTRIN | Search PIROXICAM+BETA+CYCLODEXTRIN |
| 8 | RS ETODOLAC | 65984 | 0% | 67% | 2 | Search RS+ETODOLAC | Search RS+ETODOLAC |
| 9 | 1R MENTHYL CHLOROFORMATE | 49489 | 0% | 100% | 1 | Search 1R+MENTHYL+CHLOROFORMATE | Search 1R+MENTHYL+CHLOROFORMATE |
| 10 | 2 ETHYLPHENYL HYDRAZINE HYDROCHLORIDE | 49489 | 0% | 100% | 1 | Search 2+ETHYLPHENYL+HYDRAZINE+HYDROCHLORIDE | Search 2+ETHYLPHENYL+HYDRAZINE+HYDROCHLORIDE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | BALFOUR, JA , BUCKLEY, MMT , (1991) ETODOLAC - A REAPPRAISAL OF ITS PHARMACOLOGY AND THERAPEUTIC USE IN RHEUMATIC DISEASES AND PAIN STATES.DRUGS. VOL. 42. ISSUE 2. P. 274 -299 | 65 | 83% | 35 |
| 2 | JUBB, RW , PLATT, P , PRICE, TR , (1992) DOUBLE-BLIND COMPARISON OF ETODOLAC SUSTAINED-RELEASE TABLETS AND PIROXICAM CAPSULES IN PATIENTS WITH RHEUMATOID-ARTHRITIS - AN INTERIM-REPORT.CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL. VOL. 52. ISSUE 6. P. 769-779 | 24 | 92% | 5 |
| 3 | KHAN, FM , WILLIAMS, PI , (1992) DOUBLE-BLIND COMPARISON OF ETODOLAC SR AND DICLOFENAC SR IN THE TREATMENT OF PATIENTS WITH DEGENERATIVE JOINT DISEASE OF THE KNEE.CURRENT MEDICAL RESEARCH AND OPINION. VOL. 13. ISSUE 1. P. 1-12 | 23 | 92% | 8 |
| 4 | SCHATTENKIRCHNER, M , (1991) DOUBLE-BLIND COMPARISON OF ETODOLAC AND PIROXICAM IN PATIENTS WITH RHEUMATOID-ARTHRITIS.CURRENT MEDICAL RESEARCH AND OPINION. VOL. 12. ISSUE 8. P. 497-506 | 23 | 96% | 6 |
| 5 | CHEN, YF , JOBANPUTRA, P , BARTON, P , BRYAN, S , FRY-SMITH, A , HARRIS, G , TAYLOR, RS , (2008) CYCLOXYGENASE-2 SELECTIVE NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (ETODOLAC, MELOXICAM, CELECOXIB, ROFECOXIB, ETORICOXIB, VALDECOXIB AND LUMIRACOXIB) FOR OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS: A SYSTEMATIC REVIEW AND ECONOMIC EVALUATION.HEALTH TECHNOLOGY ASSESSMENT. VOL. 12. ISSUE 11. P. 1 -+ | 53 | 19% | 102 |
| 6 | HUMBER, LG , (1987) ETODOLAC - THE CHEMISTRY, PHARMACOLOGY, METABOLIC DISPOSITION, AND CLINICAL PROFILE OF A NOVEL ANTIINFLAMMATORY PYRANOCARBOXYLIC ACID.MEDICINAL RESEARCH REVIEWS. VOL. 7. ISSUE 1. P. 1-28 | 30 | 83% | 38 |
| 7 | PORZIO, F , SCHATTENKIRCHNER, M , (1993) DOUBLE-BLIND COMPARISON OF ETODOLAC SUSTAINED-RELEASE TABLETS AND DICLOFENAC SUSTAINED-RELEASE TABLETS IN PATIENTS WITH RHEUMATOID-ARTHRITIS - AN INTERIM-REPORT.CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL. VOL. 53. ISSUE 2. P. 144-153 | 21 | 91% | 4 |
| 8 | LYNCH, S , BROGDEN, RN , (1986) ETODOLAC - A PRELIMINARY REVIEW OF ITS PHARMACODYNAMIC ACTIVITY AND THERAPEUTIC USE.DRUGS. VOL. 31. ISSUE 4. P. 288-300 | 29 | 91% | 19 |
| 9 | SILVA, CD , ROCHA, A , TOZATTO, E , DA SILVA, LM , DONADI, EA , LANCHOTE, VL , (2016) ENANTIOSELECTIVE ANALYSIS OF ETODOLAC IN HUMAN PLASMA BY LC-MS/MS: APPLICATION TO CLINICAL PHARMACOKINETICS.JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. VOL. 120. ISSUE . P. 120 -126 | 17 | 55% | 0 |
| 10 | MARSH, CC , SCHUNA, AA , SUNDSTROM, WR , (1986) A REVIEW OF SELECTED INVESTIGATIONAL NONSTEROIDAL ANTIINFLAMMATORY DRUGS OF THE 1980S.PHARMACOTHERAPY. VOL. 6. ISSUE 1. P. 10-25 | 39 | 63% | 26 |
Classes with closest relation at Level 1 |